Amphetamine Prescribing as a Harm Reduction Measure: A Preliminary Study

References

• Clee W. B., Hunter P. R. Hepatitis B in general practice: epidemiology, clinical and serological features, and control. British Medical Journal 1987; 295: 530–532
   PubMed Web of Science ®Google Scholar
• Darke S., Hall W., Heather N., Wodak A., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opioid users: The Opiate Treatment Index. British Journal of Addiction 1992; 87: 593–602
   Google Scholar
• Darke S., Cohen J., Ross J., Hando J., Hall W. Transitions between routes of administration of regular amphetamine users. Addiction 1994; 89(9)1077–1083
   PubMedGoogle Scholar
• Department of Health. Drug Misuse and Dependence: Guidelines on Clinical Management. HMSO, London 1991
   Google Scholar
• Diaz T., Chu S. Y., Byers R. H., Hersh B. S., Conti L., Rietmeijer C. A., Mokotoff E., Fann A., Boyd D., Iglesias D., Checko P. J., Frederick M., Hermann P., Herr M., Samuel M. C. The types of drugs used by HIV infected injecting drug users in a multistate surveillance project: implications for intervention. American Journal of Public Health 1994; 84(12)1971–1975
   PubMed Web of Science ®Google Scholar
• Farrell J., Ward J., Mattick R., Hall W., Stimson G. V., des Jaiiais D., Gossop M., Strang J. Methadone maintenance treatment in opiate dependence: a review. British Medical Journal 1994; 309: 997–1001
   PubMed Web of Science ®Google Scholar
• Fleming P. M., Roberts D. Is the prescription of amphetamine justified as a harm reduction measure. Journal of the Royal Society of Health 1994; 2: 127–131
   Google Scholar
• Ford P. Amphetamine prescribing intervention. Scoda Newsletter. 1993, December 1992-January, 10-11
   Google Scholar
• Gillman G., Goodman L. S., Rail T. W., Murad F. The Pharmacological Basis of Therapeutics 7th Edition. McMillan Publishing Company, New York 1985
   Google Scholar
• Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607–614
   PubMed Web of Science ®Google Scholar
• Hall W., Hando J. Route of Administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug and Alcohol Review 1994; 13(3)277–284
   PubMedGoogle Scholar
• Institute for the Study of Drug Dependence. Drug Misuse in Britain 1994. Institute for the Study of Drug Dependence, London 1994
   Google Scholar
• Kail K., Niisonne A. Preference lor sex on amphetamine: a marker for HIV risk behaviour among male intravenous amphetamine users in Stockholm. AIDS Care 1995; 7(2)171–188
   PubMedGoogle Scholar
• Khantzian E. J., Gawin F., Kleber H. D., Riordan C. E. Methylphenidate (Ritalin) treatment of cocaine dependence–a preliminary report. Journal of Substance Abuse Treatment 1984; 1: 107–112
   PubMedGoogle Scholar
• Klee H. A new target for behavioural research–amphetamine misuse. British Journal of Addiction 1992; 87: 439–446
   PubMedGoogle Scholar
• Klee H. HIV risks for women drug injectors: heroin and amphetamine users compared. Addiction 1993; 88(10)1055–1062
   PubMedGoogle Scholar
• Klee H., Morris J. Factors that lead young amphetamine users to seek help: implications for drug prevention and harm reduction. Drugs: Education, Prevention and Policy 1994; 1(3)289–297
   Web of Science ®Google Scholar
• Lago J. A., Kosten T. R. Stimulant withdrawal. Addiction 1994; 89(11)1477–1481
   PubMed Web of Science ®Google Scholar
• McBride A. J. Cannabis use in a drug and alcohol clinic population. Drug and Alcohol Dependence 1995; 39: 29–32
   PubMed Web of Science ®Google Scholar
• Miller N. S., Summers G. L., Gold M. S. Cocaine dependence: alcohol and other drug dependence and withdrawal characteristics. Journal of Addictive Diseases 1993; 12(1)25–35
   PubMedGoogle Scholar
• Mitcheson M., Edwards G., Hawks D., Ogborne A. Treatment of Methylamphetamine Users during the 1968 Epidemic, G. Edwards, M. A. H. Russell, D. Hawks, M. MacCafferty. Drugs and Drug Dependence), Saxon House, Farnborough 1976
   Google Scholar
• Newcombe R. A researcher reports from the rave. Druglink 1992; 7(1)14–16
   Google Scholar
• Oswald I., Thacore V. R. Amphetamine and phenmetrazine addiction: physiological abnormalities in the abstinence syndrome. British Medical Journal 1963; 1: 427–131
   Google Scholar
• Pates R. Speed on prescription. Druglink 1994; May/June: 16–17
   Google Scholar
• Pates R., Coombes N., Ford N. A pilot program in prescribing dexamphetamine for amphetamine users. Journal of Substance Misuse 1996; 1: 80–84
   Google Scholar
• Race J., McBride A. J. The first 1000 new referrals to a new community drug team: a descriptive study. Presented to the Welsh Psychiatric Society. 1994
   Google Scholar
• Satel S. L., Price L. H., Palumbo J. M., McDougle C. J., Krystal J. H., Gawin F., Charney D. S., Heninger G. R., Kleber H. D. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. American Journal of Psychiatry 1991; 148(12)1712–1716
   PubMed Web of Science ®Google Scholar
• Sherman P. Dexamphetamine for 'speed' addiction. Medical Journal of Australia 1990; 153: 306
   PubMed Web of Science ®Google Scholar
• Standing Conference on Drug Abuse. Working with Stimulant Users. Conference Report. Standing Conference on Drug Abuse, London 1989
   Google Scholar
• Stewart D. G., Brown S. A. Withdrawal and dependency symptoms among adolescent alcohol and drug abusers. Addiction 1995; 90: 627–635
   PubMed Web of Science ®Google Scholar
• Strang J. Intermediate goals and the process of change. AIDS and Drug Misuse: The Challenge for Policy and Practice in the 1990s, J. Strang, G. Stimson. Routledge, London 1990; 211–221
   Google Scholar